PFAS compounds in drinking water are associated with accelerated epigenetic aging in older adults, with effects strongest in men aged 50–64. The longevity field systematically neglects exposure reduction despite treating inflammation—a likely mechanistic link—as central to aging interventions.
Key Points
- Higher blood PFAS levels correlate with accelerated epigenetic aging
- Environmental exposures remain absent from aging assessment protocols
- Inflammation markers suggest PFAS-aging mechanism, yet water quality ignored
Longevity Analysis
The field's asymmetric focus on supplementation and biomarker optimization obscures a foundational problem: persistent chemical exposure that activates inflammatory pathways and degrades cellular signaling. Until practitioners decode the exposome—the cumulative burden of what the body receives involuntarily—interventions targeting inflammation remain incomplete. Water quality, air filtration, and product scrutiny function as interference elimination rather than glamorous additions, yet the data linking PFAS to accelerated aging suggests they deserve the same measurement rigor applied to NAD or sleep metrics. Longevity medicine cannot optimize what it does not measure or acknowledge.
Original published by Longevity.Technology, by Guest Contributor.